Market Value1,560,198,000
Total Holdings57
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ONEM / 1life Healthcare Inc
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
CRSP / CRISPR Therapeutics AG
US74140Y1010 / Prevail Therapeutics Inc.
US74257L1089 / Principia Biopharma Inc.
BIOR / Biora Therapeutics, Inc.
SURF / Surface Oncology Inc
ZGNX / Zogenix Inc
/ Immunomedics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd.
DCPH / Deciphera Pharmaceuticals, Inc.
CHRS / Coherus Oncology, Inc.
IOVA / Iovance Biotherapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
EXEL / Exelixis, Inc.
RPRX / Royalty Pharma plc
GILD / Gilead Sciences, Inc.
ANIK / Anika Therapeutics, Inc.
BTAI / BioXcel Therapeutics, Inc.
ARVN / Arvinas, Inc.
HOLX / Hologic, Inc.
DVAX / Dynavax Technologies Corporation
018490100 / Allergan plc
CVS / CVS Health Corporation
CRL / Charles River Laboratories International, Inc.
KDMN / Kadmon Holdings Inc
US60877T1007 / Momenta Pharmaceuticals, Inc.
SYNH / Syneos Health Inc - Class A
RCUS / Arcus Biosciences, Inc.
SGEN / Seagen Inc Call
MRNA / Moderna, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
HARP / Harpoon Therapeutics, Inc.
ALEC / Alector, Inc.
AKUS / Akouos Inc
HZNP / Horizon Therapeutics Plc
MDT / Medtronic plc
AVDL / Avadel Pharmaceuticals plc
IDYA / IDEAYA Biosciences, Inc.
EDIT / Editas Medicine, Inc.
MCK / McKesson Corporation
ABBV / AbbVie Inc.
ESPR / Esperion Therapeutics, Inc.
CCXI / ChemoCentryx Inc
MRSN / Mersana Therapeutics, Inc.
SGEN / Seagen Inc
AUPH / Aurinia Pharmaceuticals Inc.
VIR / Vir Biotechnology, Inc.
NERV / Minerva Neurosciences, Inc.
NERV / Minerva Neurosciences, Inc. Call
RNA / Avidity Biosciences, Inc.
VSTM / Verastem, Inc.
TVTX / Travere Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
BAX / Baxter International Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
FUSN / Fusion Pharmaceuticals Inc.
NBIX / Neurocrine Biosciences, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
AVTR / Avantor, Inc.
AXSM / Axsome Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc.